Non–small cell lung cancer: epidemiology, screening, diagnosis, and treatment
N Duma, R Santana-Davila, JR Molina - Mayo Clinic Proceedings, 2019 - Elsevier
Lung cancer remains the leading cause of cancer deaths in the United States. In the past
decade, significant advances have been made in the science of non–small cell lung cancer …
decade, significant advances have been made in the science of non–small cell lung cancer …
Lung cancer LDCT screening and mortality reduction—evidence, pitfalls and future perspectives
In the past decade, the introduction of molecularly targeted agents and immune-checkpoint
inhibitors has led to improved survival outcomes for patients with advanced-stage lung …
inhibitors has led to improved survival outcomes for patients with advanced-stage lung …
Screening for lung cancer: 2023 guideline update from the American Cancer Society
Lung cancer is the leading cause of mortality and person‐years of life lost from cancer
among US men and women. Early detection has been shown to be associated with reduced …
among US men and women. Early detection has been shown to be associated with reduced …
Reduced lung-cancer mortality with volume CT screening in a randomized trial
HJ de Koning, CM van Der Aalst… - New England journal …, 2020 - Mass Medical Soc
Background There are limited data from randomized trials regarding whether volume-based,
low-dose computed tomographic (CT) screening can reduce lung-cancer mortality among …
low-dose computed tomographic (CT) screening can reduce lung-cancer mortality among …
[HTML][HTML] Prolonged lung cancer screening reduced 10-year mortality in the MILD trial: new confirmation of lung cancer screening efficacy
U Pastorino, M Silva, S Sestini, F Sabia, M Boeri… - Annals of …, 2019 - Elsevier
ABSTRACT Background The National Lung Screening Trial showed that lung cancer (LC)
screening by three annual rounds of low-dose computed tomography (LDCT) reduces LC …
screening by three annual rounds of low-dose computed tomography (LDCT) reduces LC …
European position statement on lung cancer screening
Lung cancer screening with low-dose CT can save lives. This European Union (EU) position
statement presents the available evidence and the major issues that need to be addressed …
statement presents the available evidence and the major issues that need to be addressed …
[HTML][HTML] Biomarkers in lung cancer screening: achievements, promises, and challenges
The present review is an update of the research and development efforts regarding the use
of molecular biomarkers in the lung cancer screening setting. The two main unmet clinical …
of molecular biomarkers in the lung cancer screening setting. The two main unmet clinical …
Global, regional, and national burden of respiratory tract cancers and associated risk factors from 1990 to 2019: a systematic analysis for the Global Burden of Disease …
Background Prevention, control, and treatment of respiratory tract cancers are important
steps towards achieving target 3.4 of the UN Sustainable Development Goals (SDGs)—a …
steps towards achieving target 3.4 of the UN Sustainable Development Goals (SDGs)—a …
ESR/ERS statement paper on lung cancer screening
HU Kauczor, AM Baird, TG Blum, L Bonomo… - European …, 2020 - Springer
In Europe, lung cancer ranks third among the most common cancers, remaining the biggest
killer. Since the publication of the first European Society of Radiology and European …
killer. Since the publication of the first European Society of Radiology and European …
Mortality, survival and incidence rates in the ITALUNG randomised lung cancer screening trial
E Paci, D Puliti, AL Pegna, L Carrozzi, G Picozzi… - Thorax, 2017 - thorax.bmj.com
Background ITALUNG is contributing to the European evaluation of low-dose CT (LDCT)
screening for lung cancer (LC). Methods Eligible subjects aged 55–69 years, smokers or ex …
screening for lung cancer (LC). Methods Eligible subjects aged 55–69 years, smokers or ex …